Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells

Significant inhibition of proliferative activity in PC3 human prostate cancer cells by estradiol is reported, accompanied by experimental evidence for a specific estrogen receptor (ER). Radioligand-binding assays revealed the presence of high affinity sites of estrogen binding in the nuclear compart...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 1994-03, Vol.54 (5), p.1190-1193
Main Authors: CARRUBA, G, PFEFFER, U, FECAROTTA, E, COVIELLO, D. A, D'AMATO, E, LO CASTO, M, VIDALI, G, CASTAGNETTA, L
Format: Article
Language:English
Subjects:
Antineoplastic agents
Biological and medical sciences
Blotting, Northern
Blotting, Southern
Cell Division - drug effects
Chemotherapy
Estradiol - pharmacology
Humans
Kinetics
Male
Medical sciences
Neoplasms, Hormone-Dependent - drug therapy
Neoplasms, Hormone-Dependent - pathology
Neoplasms, Hormone-Dependent - ultrastructure
Pharmacology. Drug treatments
Polymerase Chain Reaction
Prostatic Neoplasms - drug therapy
Prostatic Neoplasms - pathology
Prostatic Neoplasms - ultrastructure
Receptors, Estrogen - genetics
Receptors, Estrogen - physiology
RNA, Messenger - analysis
Transforming Growth Factor beta - genetics
Transforming Growth Factor beta - physiology
Tumor Cells, Cultured - drug effects
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Significant inhibition of proliferative activity in PC3 human prostate cancer cells by estradiol is reported, accompanied by experimental evidence for a specific estrogen receptor (ER). Radioligand-binding assays revealed the presence of high affinity sites of estrogen binding in the nuclear compartment of PC3 cells. In addition, using a reverse transcriptase-polymerase chain reaction system, we obtained evidence of either normal or a variant ER mRNA; the latter, which lacks the entire exon 4, is coexpressed with normal ER mRNA and has been recently characterized in our laboratories. The likelihood that the inhibitory effect exerted by estradiol could be mediated by an increase of transforming growth factor beta (TGF beta) production was also investigated. Use of monoclonal antibodies against TGF beta 1 produced a 3-fold increase of growth rate in PC3 cells; this clearly speaks for high levels of endogenous TGF beta 1. This effect was almost completely abolished after addition of 100 nM estradiol. However, we failed to demonstrate any increase of TGF beta 1 mRNA after estradiol administration using Northern blot analysis. Further studies are needed to ascertain whether the estradiol-induced growth inhibition of PC3 cells is either mediated by other TGF beta species or exerted via alternative mechanism(s).
ISSN:0008-5472
1538-7445